Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             87 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absence of altered in vivo concentration of dorsolateral prefrontal cortex GABA in recent onset schizophrenia Yoon, Jong H.

243 C p. 383-384
artikel
2 Accessibility of psychiatric vocabulary: An international study about schizophrenia essential features Askevis-Leherpeux, Françoise

243 C p. 463-464
artikel
3 Adaptive and maladaptive consequences of increased social media and internet use during the COVID-19 pandemic in schizophrenia Zhang, Luyu

243 C p. 472-474
artikel
4 Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis Macdonald, Kelsey I.

243 C p. 446-448
artikel
5 Aerobic exercise and cognitive functioning in schizophrenia: Findings of dose-response analysis from a pilot randomized controlled trial Shimada, Takeshi

243 C p. 443-445
artikel
6 Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study Stephane, Massoud

243 C p. 475-480
artikel
7 A meta-analysis of social cognitive deficits in schizophrenia: Does world region matter? Weinreb, Susannah

243 C p. 206-213
artikel
8 Amitriptyline for clozapine-induced hypersalivation: A case series Cereda, Guido

243 C p. 110-111
artikel
9 AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding Yonezawa, Kengo

243 C p. 98-109
artikel
10 An opportunity for primary prevention research in psychotic disorders Gershon, Elliot S.

243 C p. 433-439
artikel
11 An overall protective effect of antipsychotic drugs against COVID-19 seems implausible Ruiz de Pellón-Santamaría, Ángel

243 C p. 486-488
artikel
12 Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness Cavaliere, Vincent S.

243 C p. 163-169
artikel
13 Antipsychotics and Attenuated Psychosis Syndrome: Transdiagnostic assessment and discontinuation strategies Fusar-Poli, Paolo

243 C p. 402-404
artikel
14 A potential objective marker in first-episode schizophrenia based on abnormal niacin response Hu, YeGang

243 C p. 405-412
artikel
15 A proxy measure of premorbid adjustment in psychosis for large-scale epidemiological studies and electronic health record-based research López-Díaz, Álvaro

243 C p. 467-469
artikel
16 A redux of schizophrenia research in 2021 Suhas, Satish

243 C p. 458-461
artikel
17 Assessment of treatment resistance criteria in non-invasive brain stimulation studies of schizophrenia Kronick, Jami

243 C p. 349-360
artikel
18 Association between incarceration and psychotic experiences in a general population sample Narita, Zui

243 C p. 112-117
artikel
19 Association of g-quadruplex variants with schizophrenia symptoms Bhattacharyya, Upasana

243 C p. 361-363
artikel
20 Attaching importance to the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia Tang, Chao-Hsiun

243 C p. 462
artikel
21 (Attenuated) hallucinations join basic symptoms in a transdiagnostic network cluster analysis Jimeno, Natalia

243 C p. 43-54
artikel
22 Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia? Mamtani, Harkishan

243 C p. 203-205
artikel
23 Childhood trauma is associated with poorer social functioning in severe mental disorders both during an active illness phase and in remission Hjelseng, Ingrid Varvin

243 C p. 241-246
artikel
24 Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia Bioque, Miquel

243 C p. 32-42
artikel
25 Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences Raballo, Andrea

243 C p. 254-261
artikel
26 Computerised cognitive training during early-stage psychosis improves cognitive deficits and gamma-band oscillations: A pilot study Haining, Kate

243 C p. 217-219
artikel
27 Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis de Filippis, Renato

243 C p. 451-453
artikel
28 COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey Costardi, Carlos Gustavo

243 C p. 465-466
artikel
29 Disparities in technology literacy and access negatively impact cognitive remediation scalability Arlia, Christina

243 C p. 456-457
artikel
30 Editorial Board
243 C p. IFC
artikel
31 Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study Eger, G.

243 C p. 247-253
artikel
32 Effects of paranoia on well-being in adolescents: A longitudinal mediational analysis Kingston, J.L.

243 C p. 178-180
artikel
33 Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of neurodevelopmental disorders: Prenatal immune activation and peripubertal stress Capellán, Roberto

243 C p. 232-240
artikel
34 Fatigue in psychosis Poole-Wright, K.

243 C p. 392-394
artikel
35 Further evidence and meta-analysis support association of a single nucleotide polymorphism rs4765905 in CACNA1C with schizophrenia Wang, Zuxing

243 C p. 454-455
artikel
36 Gender differences in the association between environment and psychosis Pence, Aysegul Yay

243 C p. 120-137
artikel
37 Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction? Steiner, Johann

243 C p. 483-485
artikel
38 Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts? Formica, M.J.C.

243 C p. 276-284
artikel
39 Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging Higuchi, Cinthia H.

243 C p. 424-430
artikel
40 Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features Barlati, Stefano

243 C p. 364-371
artikel
41 In this issue
243 C p. A1
artikel
42 Investigation of accelerated epigenetic aging in individuals experiencing suicidal ideation Dada, Oluwagbenga

243 C p. 307-309
artikel
43 Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attempt Jeremian, Richie

243 C p. 222-224
artikel
44 It's never too late to admit it's too early! Malhi, Gin S.

243 C p. 296-297
artikel
45 Letter to the editor: The critical eye of science should know no borders Chang, Bernard P.

243 C p. 413
artikel
46 Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study Ranjan, Tanvi

243 C p. 64-69
artikel
47 Means of suicide in psychiatric patients: Population-based data from Israel between 2001 and 2020 Bergman-Levy, Tal

243 C p. 118-119
artikel
48 Metamotivation in people diagnosed with schizophrenia: A conceptual introduction and qualitative study Hansen, Marie C.

243 C p. 317-321
artikel
49 Multimorbidity landscape of schizophrenia: Insights from meta-analysis of genome wide association studies Gawde, Ulka

243 C p. 214-216
artikel
50 Negative schizotypy attenuates the effect of momentary stress on social dysfunction related to COVID-19 social distancing Masucci, Michael D.

243 C p. 24-31
artikel
51 Network signatures of rTMS treatment in patients with schizophrenia and auditory verbal hallucination during an auditory-motor task using HD-EEG Banea, Ovidiu C.

243 C p. 310-314
artikel
52 Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the ‘enfacement’ paradigm Salgado-Pineda, Pilar

243 C p. 395-401
artikel
53 Neurocognitive and social cognitive training for youth at clinical high risk (CHR) for psychosis: A randomized controlled feasibility trial Friedman-Yakoobian, Michelle S.

243 C p. 302-306
artikel
54 Neurodegenerative model of schizophrenia: Growing evidence to support a revisit Stone, William S.

243 C p. 154-162
artikel
55 Neurometabolic patterns of an “at risk for mental disorders” syndrome involve abnormalities in the thalamus and anterior midcingulate cortex Smesny, Stefan

243 C p. 285-295
artikel
56 New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus Yesilkaya, Umit Haluk

243 C p. 315-316
artikel
57 North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description Addington, Jean

243 C p. 262-267
artikel
58 Plasma lipid alterations in young adults with psychotic experiences: A study from the Avon Longitudinal Study of Parents and Children cohort Yin, Xiaofei

243 C p. 78-85
artikel
59 Population density is unrelated to prevalence of psychotic experience across 4 U.S. cities Marsh, Jonathan

243 C p. 449-450
artikel
60 Pragmatic implementation of the Clinical Global Impression Scale of Severity as a tool for measurement-based care in a first-episode psychosis program Khau, Michelle

243 C p. 147-153
artikel
61 Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings Igata, Ryohei

243 C p. 431-432
artikel
62 Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study Rubin, Leah H.

243 C p. 489-499
artikel
63 Recent health-related stressful life events predictive of emergent suicidal ideation in schizophrenia Tasmim, Samia

243 C p. 220-221
artikel
64 Reducing public stigma toward individuals with psychosis across race and gender: A randomized controlled trial of young adults Amsalem, Doron

243 C p. 195-202
artikel
65 Relationship between plasma clozapine/N-desmethylclozapine and changes in basal forebrain-dorsolateral prefrontal cortex coupling in treatment-resistant schizophrenia Sarpal, Deepak K.

243 C p. 170-177
artikel
66 Reply to Evans et al.: Towards informed choice in cannabis use Holt, Daphne J.

243 C p. 481-482
artikel
67 Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline Murray, R.M.

243 C p. 181-186
artikel
68 Sex and gender associations with indicators of neurodevelopmental compromise in schizophrenia spectrum disorders Luckhoff, Hilmar Klaus

243 C p. 70-77
artikel
69 Sex differences in antipsychotic-related triglyceride levels are associated with metabolic hormone differences in patients with severe mental disorders Johansen, Ingrid Torp

243 C p. 55-63
artikel
70 Shortening telomere is associated with psychotic dimensions in the general population Schürhoff, Franck

243 C p. 470-471
artikel
71 Spared performance but increased uncertainty in schizophrenia: Evidence from a probabilistic decision-making task Kreis, Isabel

243 C p. 414-423
artikel
72 Starting clozapine in patients with schizophrenia during the ongoing pandemic Grover, Sandeep

243 C p. 440-442
artikel
73 Striatal functional connectivity in psychosis relapse: A hypothesis generating study Rubio, Jose M.

243 C p. 342-348
artikel
74 Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks Hu, Mengjiao

243 C p. 330-341
artikel
75 Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study Takahashi, Tsutomu

243 C p. 268-275
artikel
76 The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder Alphs, Larry

243 C p. 86-97
artikel
77 The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic randomized open-label trial (SwAP trial) Shakir, Mushde

243 C p. 187-194
artikel
78 The effects of voice content on stress reactivity: A simulation paradigm of auditory verbal hallucinations Baumeister, David

243 C p. 225-231
artikel
79 The potential role of self-criticism in distress related to attenuated psychotic symptoms and implications for clinical trajectory Hickey, Tara

243 C p. 298-299
artikel
80 The role of insecure attachment and psychological mechanisms in paranoid and depressive symptoms: An exploratory model Trucharte, Almudena

243 C p. 9-16
artikel
81 The trajectories and correlates of two negative symptom subdomains in first-episode schizophrenia Phahladira, Lebogang

243 C p. 17-23
artikel
82 The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia Clayson, Peter E.

243 C p. 372-382
artikel
83 The 10-year trajectories of auditory hallucinations among 496 patients with a first schizophrenia-spectrum disorder: Findings from the OPUS cohort Köhler-Forsberg, Ole

243 C p. 385-391
artikel
84 Three major psychiatric disorders share specific dynamic alterations of intrinsic brain activity Zhang, Luheng

243 C p. 322-329
artikel
85 Unpacking the phenomenon of declining transition rates to first episode psychosis: The dyad of science and service reform in action Daneault, Jean-Gabriel

243 C p. 300-301
artikel
86 We both say tomato: Intact lexical alignment in schizophrenia and bipolar disorder Sharpe, Victoria

243 C p. 138-146
artikel
87 What is obsession? Differentiating obsessive-compulsive disorder and the schizophrenia spectrum Rasmussen, Andreas Rosén

243 C p. 1-8
artikel
                             87 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland